Eli Lilly announced an update on its Phase 3 clinical study testing Mirikizumab for pediatric Crohn’s disease, showing real ...

Truist Financial trimmed its Walmart stake by 1% in Q1, selling 38,194 shares worth over $339 million. Walmart’s stock slid 2 ...

UnitedHealth Group defied market trends, closing up 1.31% while broader indices faltered slightly. The company’s stock rose ...

Salesforce’s stock had a dramatic year, swinging between $230 and $369 while leaving investors scratching their heads. The ...

Hudson Edge Investment Partners slashed its Johnson & Johnson stake by 18.1% in the first quarter, selling nearly 9,000 ...

Resonant Capital Advisors boosted its Exxon Mobil stake by 7.3% in Q1, adding 3,526 shares to hold 51,869 worth over $6.1M.

Bank of America earned a consensus "Moderate Buy" rating from twenty-six analysts with an average price target of $48.33.

Barclays is standing its ground with an “Overweight” rating on Mastercard, shrugging off the much-hyped stablecoin threat.

AbbVie shines as a blue-chip powerhouse, proving stability and growth go hand in hand. The company’s stock climbed 1.26% in a ...

San Francisco’s Union Square has struggled post-pandemic, riddled with store closures, vacancies, and safety concerns despite ...

Oracle’s recent financial wins highlight its cloud and AI leadership, but a $2.33M insider sale by its CFO sparked debate.

Costco is leveling up its stagflation defense with global expansion and smart tech. The retailer plans to open up to 29 new ...